Borel-Derlon, A <br/><br/>
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  Jun 2007 
 - 1115-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7933 
<br/><br/><label>Standard No.: </label>10.1111/j.1538-7836.2007.02562.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Child<br/>Child, Preschool<br/>Factor VIII--administration & dosage<br/>Female<br/>Hemorrhage--drug therapy<br/>Hemostasis--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Postoperative Hemorrhage--drug therapy<br/>Prospective Studies<br/>Safety<br/>von Willebrand Diseases--drug therapy<br/>von Willebrand Factor--administration & dosage